Public Joint Stock Company "Farmak" engages in the manufacturing and sale of pharmaceutical products in Ukraine. The company provides drugs in the areas of dermatology, cardiovascular system, influenza and acute respiratory viral infections (ARVIs), genito-urinary system and sex hormones, acute and chronic hepatitis, fatty liver and cirrhosis, gall bladder, spleen, pancreas, diarrhea, alimentary tract and metabolism, venous and lymphatic failures, systemic hormonal preparations, anti-infectives, heart diseases, sensory organs, diabetics, respiratory system, musculo-skeletal system, nausea, allergic rhinitis, nervous system, allergic diseases, fungal infections, erectile dysfunction, blood and blood forming organs, and pain syndrome. It also offers products in antineoplastic and immunomodulating agents, schizophrenia, antiviral agents, infectious diseases and inflammatory processes, degenerative and dystrophic diseases, antiviral, antimicrobial, anti-inflammatory, immunomodulatory drugs, child and infant products, and other therapeutic areas, as well as antiparasitic products, insecticides, repellents, and dietary supplements. In addition, the company engages in contract manufacturing activities. It is also involved in exporting activities. The company was founded in 1925 and is headquartered in Kyiv, Ukraine. Public Joint Stock Company "Farmak" operates as a subsidiary of F.I.& P. Holdings Limited.